Finally, Italy is also aligning itself with the 2014 EMA recommendations, which provided for the purchase of the drug ulipristal acetate (EllaOne), the five-day-after pill, without a medical prescription. All European countries had complied, except Italy and Hungary. Decision taken by Aifa with determination no. 998 of 08/10/2020. So it will no longer be necessary to have a medical prescription to dispense ulipristal acetate (EllaOne) to minors, the drug used for emergency contraception up to five days after intercourse. Ulipristal acetate, a highly effective drug for emergency contraception for young women who have had unprotected intercourse, within five days of intercourse. Drug for emergency contraception, it is not to be used regularly. The drug is accompanied by an information leaflet aimed at promoting informed and effective contraception and avoiding inappropriate use of emergency contraception. The majority of teenage pregnancies, in fact, are unplanned and many end in abortion. Therefore, the drug promises a breakthrough in protecting the physical and psychological health of adolescents. Teenage pregnancy is also associated with a higher risk of perinatal morbidity/mortality. In fact, the increased use of emergency contraception levonorgestrel (Norlevo), the “morning after pill,” and ulipristal acetate (EllaOne), the five-day-after pill, has had a positive impact on the reduction of voluntary pregnancy terminations (IVG), which has been continuously and progressively decreasing since 1983. Eliminating the prescription requirement was the right choice, which should have come much earlier. As often happens in Italy, there is a lack of courage to make the right choices. LapaginadiNursingUp


